Aulmann et al. reported the molecular characterization of 65 cases of vulvovaginal melanoma, finding no BRAF mutations but NRAS mutations and KIT amplifications in 12% of both vulvar and vaginal tumors. This evidence concerns the gene BRAF and vaginal neoplasm.